Affordable Access

deepdyve-link
Publisher Website

Committee Opinion No. 545: Noninvasive prenatal testing for fetal aneuploidy.

Authors
Type
Published Article
Journal
Obstetrics and Gynecology
Publisher
Ovid Technologies (Wolters Kluwer) - Lippincott Williams & Wilkins
Publication Date
Dec 01, 2012
Volume
120
Issue
6
Pages
1532–1534
Identifiers
DOI: 10.1097/01.AOG.0000423819.85283.f4
PMID: 23168792
Source
Medline
License
Unknown

Abstract

Noninvasive prenatal testing that uses cell free fetal DNA from the plasma of pregnant women offers tremendous potential as a screening tool for fetal aneuploidy. Cell free fetal DNA testing should be an informed patient choice after pretest counseling and should not be part of routine prenatal laboratory assessment. Cell free fetal DNA testing should not be offered to low-risk women or women with multiple gestations because it has not been sufficiently evaluated in these groups. A negative cell free fetal DNA test result does not ensure an unaffected pregnancy. A patient with a positive test result should be referred for genetic counseling and should be offered invasive prenatal diagnosis for confirmation of test results.

Report this publication

Statistics

Seen <100 times